BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2170995)

  • 1. Management of patients with non-seminomatous germ cell tumours stage I.
    Rørth M; Cullen MH; Horwich A; Roth BJ
    Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there still a place for lymphadenectomy in clinical stage I non-seminoma?
    Weissbach L; Boedefeld EA; Bussar-Maatz R; Kleinschmidt K
    Prog Clin Biol Res; 1988; 269():407-17. PubMed ID: 2839848
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-seminomatous germ cell testis tumors--how do you manage clinical state IIA?
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():571-4. PubMed ID: 3008185
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
    Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
    Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of clinical staging and efficacy of treatment in non-seminomatous germ-cell tumours of the testis.
    de Kock ML; Allen FJ; Breytenbach IH; van der Merwe AM
    S Afr J Surg; 1987 Sep; 25(3):87-9. PubMed ID: 2825363
    [No Abstract]   [Full Text] [Related]  

  • 7. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
    von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ
    Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemo-radiotherapeutic treatment of non-seminoma germ cell tumors of the testis in the advanced stage].
    Krengli M; Pastore G; Invernizzi A; Maffei S
    Minerva Med; 1987 Feb; 78(4):209-13. PubMed ID: 3031548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relapses of malignant nonseminomatous germinal testicular tumors].
    Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
    J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic significance of retroperitoneal lymph node dissection in low stage and localized disease: point of view.
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():263-8. PubMed ID: 3008179
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonoperative approach for the management of clinical stage A nonseminomatous germ cell tumors.
    Jewett MA
    Semin Urol; 1984 Nov; 2(4):204-7. PubMed ID: 6095394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
    Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
    Raghavan D; Boyer M
    Prog Clin Biol Res; 1990; 350():309-18. PubMed ID: 2166960
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D; Farmakis D; Pectasides M
    Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.